1. Home
  2. AKBA vs BBSI Comparison

AKBA vs BBSI Comparison

Compare AKBA & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.24

Market Cap

729.1M

Sector

Health Care

ML Signal

HOLD

Logo Barrett Business Services Inc.

BBSI

Barrett Business Services Inc.

HOLD

Current Price

$27.70

Market Cap

711.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKBA
BBSI
Founded
2007
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
729.1M
711.6M
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
AKBA
BBSI
Price
$1.24
$27.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$5.75
$42.67
AVG Volume (30 Days)
3.4M
246.1K
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
1.15%
EPS Growth
93.94
5.05
EPS
N/A
2.08
Revenue
N/A
$920,432,000.00
Revenue This Year
$17.63
$9.89
Revenue Next Year
N/A
$5.58
P/E Ratio
N/A
$13.38
Revenue Growth
N/A
9.50
52 Week Low
$1.14
$25.33
52 Week High
$4.08
$49.65

Technical Indicators

Market Signals
Indicator
AKBA
BBSI
Relative Strength Index (RSI) 41.07 26.88
Support Level $1.14 N/A
Resistance Level $1.57 $37.80
Average True Range (ATR) 0.10 1.60
MACD 0.01 -0.49
Stochastic Oscillator 18.48 22.58

Price Performance

Historical Comparison
AKBA
BBSI

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

Share on Social Networks: